Skip to main content
. 2013 Mar 4;8(3):e57436. doi: 10.1371/journal.pone.0057436

Figure 1. In malignant ovarian tumors, TWEAK/Fn14 expression was not corrected with patients’ clinical subtype/stages or pathological features.

Figure 1

(A) The expression profile of TWEAK and Fn14 in different ovarian tissues (*p<0.0001, χ2 test, α = 0.05). (B) The expression profile of TWEAK and Fn14 in malignant ovarian tumors with different pathological type. (C) The expression profile of TWEAK and Fn14 in malignant ovarian tissues with different clinical stage (based on FIGO 2000). (D) The expression profile of TWEAK and Fn14 in malignant ovarian tissues of patents with different clinical information.